Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 24 Data from a Phase 2/3 Trial.

被引：0
|
作者：
Khanna, Dinesh [1 ]
Denton, Christopher P. [2 ]
van Laar, Jacob M. [3 ]
Jahreis, Angelika [4 ]
Cheng, Sabrina [4 ]
Spotswood, Helen [5 ]
Siegel, Jeffrey [4 ]
Furst, Daniel E.
机构：
[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[2] UCL, Sch Med, London W1N 8AA, England
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
RECEPTOR; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
874
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: WEEK 24 DATA FROM A PHASE II/II TRIAL
    Denton, Christopher P.
    Khanna, Dinesh
    van Laar, Jaap M.
    Jahreis, Angelika
    Cheng, Sabrina
    Spotswood, Helen
    Siegel, Jeffrey
    Furst, Daniel E.
    [J]. RHEUMATOLOGY, 2015, 54 : 32 - 32
  • [2] SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: 24 AND 48 WEEK SAFETY AND EFFICACY DATA FROM THE FASSCINATE TRIAL
    Denton, Christopher
    Khanna, Dinesh
    Jahreis, Angelika
    van Laar, Jacob M.
    Cheng, Sabrina
    Spotswood, Helen
    Pope, Janet E.
    Allanore, Yannick
    Mueller-Ladner, Ulf
    Siegel, Jeffrey
    Furst, Daniel E.
    [J]. RHEUMATOLOGY, 2016, 55 : 47 - 48
  • [3] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: WEEK 48 DATA FROM THE FASSCINATE TRIAL
    Khanna, D.
    Denton, C. P.
    Jahreis, A.
    van Laar, J. M.
    Cheng, S.
    Spotswood, H.
    Pope, J. E.
    Allanore, Y.
    Mueller-Ladner, U.
    Siegel, J.
    Furst, D. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 87 - 88
  • [4] Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
    Khanna, Dinesh
    Denton, Christopher P.
    Jahreis, Angelika
    van Laar, Jacob M.
    Frech, Tracy M.
    Anderson, Marina E.
    Baron, Murray
    Chung, Lorinda
    Fierlbeck, Gerhard
    Lakshminarayanan, Santhanam
    Allanore, Yannick
    Pope, Janet E.
    Riemekasten, Gabriela
    Steen, Virginia
    Mueller-Ladner, Ulf
    Lafyatis, Robert
    Stifano, Giuseppina
    Spotswood, Helen
    Chen-Harris, Haiyin
    Dziadek, Sebastian
    Morimoto, Alyssa
    Sornasse, Thierry
    Siegel, Jeffrey
    Furst, Daniel E.
    [J]. LANCET, 2016, 387 (10038): : 2630 - 2640
  • [5] Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Spotswood, Helen
    Siegel, Jeffrey
    Furst, Daniel
    Denton, Christopher
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL
    Khanna, D.
    Lin, C. J. F.
    Spotswood, H.
    Siegel, J.
    Furst, D.
    Denton, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 390 - 390
  • [7] Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial (vol 387, pg 2630, 2016)
    Khanna, D.
    Denton, C. P.
    Jahreis, Angelika A.
    [J]. LANCET, 2018, 391 (10128): : 1356 - 1356
  • [8] Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Kuwana, Masataka
    Allanore, Yannick
    Batalov, Anastas
    Butrimiene, Irena
    Carreira, Patricia
    Cerinic, Marco Matucci
    Distler, Oliver
    Kaliterna, Dusanka Martinovic
    Mihai, Carina
    Mogensen, Mette
    Olesinska, Marzena
    Pope, Janet E.
    Riemekasten, Gabriela
    Rodriguez-Reyna, Tatiana S.
    Jose Santos, Maria
    van Laar, Jacob
    Spotswood, Helen
    Siegel, Jeffrey
    Jahreis, Angelika
    Furst, Daniel E.
    Denton, Christopher P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
    Brunner, Hermine
    Ruperto, Nicolino
    Zuber, Zbigniew
    Keane, Caroline
    Harari, Olivier
    Kenwright, Andrew
    Cuttica, Ruben J.
    Keltsev, Vladimir
    Xavier, Ricardo
    Penades, Inmaculada Calvo
    Nikishina, Irina
    Rubio-Perez, Nadina
    Alekseeva, Ekaterina
    Chasnyk, Vyacheslav
    Chavez, Jose
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Silva, Clovis A.
    Silverman, Earl D.
    Spindler, Alberto
    Lovell, D. J.
    Martini, Alberto
    De Benedetti, Fabrizio
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682
  • [10] Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from the Open-Label Period of a Phase 2 Randomized, Controlled Trial
    Khanna, Dinesh
    Denton, Christopher
    Spotswood, Helen
    Jahreis, Angelika
    van Laar, Jacob M.
    Burke, Laura
    Lin, Celia J. F.
    Pope, Janet E.
    Allanore, Yannick
    Mueller-Ladner, Ulf
    Siegel, Jeffrey
    Furst, Daniel E.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345